BlackRock Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
BIT
BFA
BlackRock Group's EW Position: Q4 2016 in Review
BlackRock Group increased its Edwards Lifesciences (EW) stake by 1.2% in Q4 2016, buying an estimated $2.34M and bringing the position to 6,134,970 shares worth $192M. The position accounts for 0.09% of the portfolio, ranked #259.
BlackRock Group first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $244M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.
- BlackRock Group held 6,134,970 shares of Edwards Lifesciences worth $192M as of Q4 2016.
- BlackRock Group bought 72,135 Edwards Lifesciences shares in Q4 2016, an estimated $2.34M.
- Edwards Lifesciences made up 0.09% of BlackRock Group's portfolio in Q4 2016, its #259 holding.
- BlackRock Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
- BlackRock Group's Edwards Lifesciences position peaked at $244M in Q3 2016.
- 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.